ACM
CNCE

Aquatic Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Aquatic Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,000
Closed -$12K – 1883
2022
Q4 		$12K Buy
+2,000
New +$10.5K ﹤0.01% 1209

Aquatic Capital Management's CNCE Position: Q1 2023 in Review

Aquatic Capital Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 2,000 shares — an estimated $12K sold.

Aquatic Capital Management first reported a position in CNCE in Q4 2022 and held it in 1 quarter. The position peaked at $12K in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

  • Aquatic Capital Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 2,000 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $12K.
  • Aquatic Capital Management first reported a position in Concert Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Aquatic Capital Management's Concert Pharmaceuticals, Inc. position peaked at $12K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Aquatic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.